Characterization of the First mecA-Positive Multidrug-Resistant Staphylococcus pseudintermedius Isolated from an

Paula Gagetti1, Laura Errecalde2, Alice R Wattam3

  • 1Servicio Antimicrobianos, INEI-ANLIS- "Dr. Carlos G. Malbrán," Buenos Aires, Argentina.

Microbial Drug Resistance (Larchmont, N.Y.)
|February 8, 2020
PubMed

Insights

The first methicillin-resistant Staphylococcus pseudintermedius (MRSP) in a human patient in Argentina was characterized. This multidrug-resistant strain highlights zoonotic risks and antimicrobial resistance gene reservoirs.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Staphylococcus pseudintermedius is a common cause of canine infections.
  • Methicillin resistance in S. pseudintermedius (MRSP) has emerged globally.
  • Understanding MRSP transmission and resistance is crucial for public health.

Observation:

  • Genomic characterization of the first MRSP strain (MRSP 8510) from a human patient in Argentina.
  • Phenotypic identification using MALDI-TOF MS and antimicrobial susceptibility testing.
  • Genetic analysis included mecA PCR, SCCmec typing, and whole-genome sequencing.

Findings:

  • MRSP 8510 exhibited resistance to six antimicrobial classes.
  • Genome analysis confirmed genes consistent with observed resistance.
  • The isolate was identified as a multidrug-resistant ST1412.

Implications:

  • Highlights the potential for zoonotic transmission of MRSP to humans.
  • Underscores the role of such pathogens as reservoirs for antimicrobial resistance genes.
  • Emphasizes the need for surveillance and characterization of emerging resistant pathogens.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...